checkAd
    Freeline Therapeutics Holdings Aktie
    0,2480
     
    USD
    0,00 %
    0,0000 USD
    Letzter Kurs 12.05.23 Nasdaq
    0,2311
     
    USD
    2.200 STK
    Geldkurs 11.05.23
    0,2480
     
    USD
    2.000 STK
    Briefkurs 11.05.23
    ISIN: US35655L1070 · WKN: A2QADU · SYM: FRLN · Großbritannien

    Neueste Nachrichten

    Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
    24.04.24 · globenewswire · Freeline Therapeutics Holdings
    Acquisition of Freeline by Syncona Becomes Effective
    20.02.24 · globenewswire · Freeline Therapeutics Holdings
    Freeline Shareholders Approve Acquisition by Syncona
    12.02.24 · globenewswire · Freeline Therapeutics Holdings
    FREELINE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Freeline Therapeutics Holdings plc - FRLN
    28.11.23 · Business Wire (engl.) · Freeline Therapeutics Holdings
    FRLN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Freeline Therapeutics Holdings plc Is Fair to Shareholders
    22.11.23 · Business Wire (engl.) · Freeline Therapeutics Holdings
    Syncona to Acquire Freeline Therapeutics
    22.11.23 · globenewswire · Freeline Therapeutics Holdings
    Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual Congress
    25.10.23 · globenewswire · Freeline Therapeutics Holdings
    Freeline to Present New Clinical Data for FLT201 in Gaucher Disease in Oral Presentation at Upcoming ESGCT 30th Annual Congress
    16.10.23 · globenewswire · Freeline Therapeutics Holdings
    Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease
    04.10.23 · globenewswire · Freeline Therapeutics Holdings
    Freeline Reports Second Quarter 2023 Financial Results and Business Highlights
    15.08.23 · globenewswire · Freeline Therapeutics Holdings
    Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call
    08.08.23 · globenewswire · Freeline Therapeutics Holdings
    Freeline to Participate in Upcoming Investor Conferences
    31.07.23 · globenewswire · Freeline Therapeutics Holdings